23.90

7.42% 1.65

After Hours: 24.46 0.56 +2.34%

Doximity Inc (DOCS)

Overview News Price History Option Chain Financials Why DOCS Down? Discussions Forecast

Doximity Inc stock is traded at $23.90, with a volume of 3.68M. It is up +7.42% in the last 24 hours and down -1.93% over the past month. Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.

Previous Close:

$22.25

Open:

$22.71

24h Volume:

3.68M

Relative Volume:

1.06

Market Cap:

$4.41B

Revenue:

$637.78M

Net Income/Loss:

$239.40M

P/E Ratio:

20.07

EPS:

1.1909

Net Cash Flow:

$307.21M

1W Performance:

+9.33%

1M Performance:

-1.93%

6M Performance:

-64.88%

1Y Performance:

-55.10%

1-Day Range:

$22.68

$23.97

1-Week Range:

$20.55

$23.97

52-Week Range:

$20.55

$76.51

Doximity Inc Stock (DOCS) Company Profile

Name

Doximity Inc

Sector

Healthcare (1112)

Industry

Health Information Services (51)

Phone

(650) 549-4330

Address

500 THIRD STREET, SUITE 510, SAN FRANCISCO

Employee

830

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

DOCS's Discussions on Twitter

Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DOCS Doximity Inc	23.90	4.11B	637.78M	239.40M	307.21M	1.1909
VEEV Veeva Systems Inc	167.30	25.98B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	56.41	8.89B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	46.01	8.89B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	83.67	6.87B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	24.68	4.30B	1.10B	112.09M	283.19M	0.6096

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-08-26	Downgrade	Evercore ISI	Outperform → In-line
Feb-09-26	Upgrade	Canaccord Genuity	Hold → Buy
Feb-06-26	Upgrade	JP Morgan	Underweight → Neutral
Jan-20-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-09-26	Initiated	RBC Capital Mkts	Outperform
Jan-08-26	Upgrade	Truist	Hold → Buy
Dec-15-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Upgrade	Raymond James	Outperform → Strong Buy
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-27-25	Upgrade	BofA Securities	Neutral → Buy
Oct-10-25	Downgrade	JP Morgan	Neutral → Underweight
Oct-01-25	Downgrade	Goldman	Neutral → Sell
Jul-09-25	Upgrade	Evercore ISI	In-line → Outperform
Jun-02-25	Upgrade	BTIG Research	Neutral → Buy
Feb-07-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-07-25	Upgrade	Piper Sandler	Neutral → Overweight
Dec-20-24	Initiated	Stephens	Equal-Weight
Dec-04-24	Initiated	Mizuho	Neutral
Nov-15-24	Initiated	Goldman	Neutral
Nov-14-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-13-24	Downgrade	Canaccord Genuity	Buy → Hold
Nov-08-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Nov-08-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight
Aug-09-24	Upgrade	Needham	Hold → Buy
Jul-18-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Apr-25-24	Upgrade	JP Morgan	Underweight → Neutral
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Jan-02-24	Upgrade	BofA Securities	Underperform → Neutral
Aug-09-23	Downgrade	Guggenheim	Buy → Neutral
Aug-09-23	Downgrade	Needham	Buy → Hold
Aug-03-23	Downgrade	Piper Sandler	Overweight → Neutral
May-01-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-31-22	Initiated	Wells Fargo	Overweight
Oct-24-22	Initiated	Evercore ISI	In-line
Oct-13-22	Initiated	BTIG Research	Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-05-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-28-22	Initiated	Berenberg	Buy
May-18-22	Reiterated	BofA Securities	Neutral
May-18-22	Reiterated	Goldman	Buy
May-18-22	Reiterated	Guggenheim	Buy
May-18-22	Reiterated	Jefferies	Buy
May-18-22	Reiterated	Morgan Stanley	Equal-Weight
May-18-22	Reiterated	Needham	Buy
Apr-07-22	Initiated	Guggenheim	Buy
Apr-04-22	Initiated	BofA Securities	Neutral
Feb-11-22	Initiated	Goldman	Buy
Dec-14-21	Downgrade	JP Morgan	Neutral → Underweight
Dec-02-21	Initiated	Jefferies	Buy
Nov-17-21	Initiated	Robert W. Baird	Outperform
Nov-10-21	Reiterated	Canaccord Genuity	Buy
Nov-10-21	Reiterated	Goldman	Neutral
Nov-10-21	Reiterated	Morgan Stanley	Equal-Weight
Nov-10-21	Reiterated	Needham	Buy
Nov-10-21	Reiterated	Piper Sandler	Overweight
Aug-26-21	Downgrade	JP Morgan	Overweight → Neutral
Jul-19-21	Initiated	Canaccord Genuity	Buy
Jul-19-21	Initiated	Goldman	Neutral
Jul-19-21	Initiated	JP Morgan	Overweight
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	Raymond James	Outperform
Jul-19-21	Initiated	SVB Leerink	Outperform
Jul-19-21	Initiated	William Blair	Outperform

View All

Doximity Inc Stock (DOCS) Latest News

07:51 AM

BofA cuts Doximity stock price target on transition year outlook - Investing.com

07:51 AM

06:43 AM

Insider Selling: Doximity (NYSE:DOCS) Insider Sells 2,427 Shares of Stock - MarketBeat

Apr 14, 2026

AI Disruption Jitters and Insider Sales Might Change The Case For Investing In Doximity (DOCS) - simplywall.st

Apr 14, 2026

Doximity interim PFO Sitaram sold $51k in DOCS stock - Investing.com

Apr 14, 2026

Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance

Apr 14, 2026

Doximity (NYSE: DOCS) interim PFO sells shares to cover option taxes - Stock Titan

Apr 14, 2026

Doximity, Inc. Stock Plummets to New 52-Week Low of $20.55 - Markets Mojo

Apr 14, 2026

Here is Why Doximity (DOCS) Still Appears Attractive - Insider Monkey

Apr 14, 2026

Apr 13, 2026

Can Doximity (DOCS) Turn Its Physician-Focused AI Ecosystem Into Durable Financial Strength? - Yahoo Finance

Apr 13, 2026

Is Doximity (NYSE:DOCS) Gaining Traction on The Russell 1000 Index? - Kalkine Media

Apr 13, 2026

DOCS Maintained by Keybanc -- Price Target Lowered to $30 - GuruFocus

Apr 13, 2026

Assessing Doximity (DOCS) Valuation After Soft Guidance And Rising AI Competition Concerns - Yahoo Finance

Apr 13, 2026

KeyCorp Issues Pessimistic Forecast for Doximity (NYSE:DOCS) Stock Price - MarketBeat

Apr 13, 2026

Doximity (DOCS) Slid on Concerns Over AI Disruption - Insider Monkey

Apr 13, 2026

KeyBanc Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $30 - Moomoo

Apr 13, 2026

Sentiment Review: Is Doximity Inc stock a hidden gemWeekly Market Summary & Weekly Market Pulse Updates - baoquankhu1.vn

Apr 13, 2026